Resources

Cancer Research Horizons adds the Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) study dataset to its growing portfolio of commercially licensable data assets.

It’s been an energising week across the UK life sciences landscape, marked by major investment, important conversations and new opportunities for our community.

Each month, our Policy and Public Affairs team will showcase how we are championing members’ voices in Government and Parliament.

Harness Therapeutics nominates HRN001 as its lead drug candidate for Huntington's disease and the formation of a clinical advisory board to support advancement towards clinical evaluation.

In this blog, Jane Wall, Managing Director of the BioIndustry Association (BIA), reflects on a roundtable with the Milken Institute and Jill Biden.

In this guest blog, Hareklea Markides, Innovation Lead - Medicines Manufacturing at Innovate UK, reflects on the UK BioIndustry Association's (BIA) annual #bioProcessUK conference.

TechBio’s potential to both transform our sector and provide precision diagnosis and care to patients is well recognised, and TechBio Boost is playing a vital role in scaling companies in this space.

FUJIFILM Biotechnologies celebrated the grand opening of its expanded site in Teesside, UK, today.

Microbiotica announces positive results in its Phase 1b First-in-Human trial, COMPOSER-1, of MB310 in ulcerative colitis (UC) patients.

Coulter Partners successfully led a search assignment for Concept Life Sciences and is pleased to announce the placement of Dr. Adam Davenport as Chief Scientific Officer (CSO).

In this blog, Abby Clark, Manufacturing Programme Manager at BIA, highlights some of the key achievements of BIA and ABPI’s Medicines Manufacturing Industry Partnership (MMIP).

To mark National Apprenticeship Week (9 - 15 February), Kent’s science and technology hub Discovery Park is calling for more young people to consider higher apprenticeships as a route into rewarding careers in STEM (Science, Technology, Engineering, and Maths).

In this guest blog, BIA member Asma Aslam, Senior Corporate Tax Manager at Frazier & Deeter, shares expert insight into the UK’s evolving R&D tax relief landscape for life sciences companies.

A bumper update today as we highlight the critical importance of building UK capability and innovation leadership as geopolitics continues to provide uncertainty.

PIR International recently partnered with Maxion Therapeutics in appointing Helen Timmis as VP of Clinical Development.

Bidwells has completed the merger of Creative Places LLP into the firm, strengthening its Science & Technology capability and further enhancing its expertise in R&D and innovation-led real estate.

ARC has launched Motherlabs Oxford, a new purpose-built life sciences accelerator space at its ARC Oxford campus, expanding its early-stage laboratory offering in response to sustained demand across the sector.

Brainomix is set to launch its new Brainomix 360 Next Generation platform at the International Stroke Conference (ISC).